As listed by each company, Sep 2026
Eli Lilly
Selected executives
6
David A. Ricks
Chair and chief executive
LM
Lucas Montarce
Chief financial officer
Daniel M. Skovronsky
Chief scientific and product officer
KC
Kenneth Custer
President, Cardiometabolic Health
JV
Jacob Van Naarden
President, Oncology and head of business development
Carole Ho
President, Neuroscience
Novo Nordisk
Selected executives
6
Maziar Mike Doustdar
President and chief executive
Karsten Munk Knudsen
Chief financial officer
Martin Holst Lange
Chief scientific officer
Emil Kongshøj Larsen
International Operations
Jamey Millar
US Operations
Kasper Bødker Mejlvang
Global Manufacturing and Supply